PMA supplement
P000029 S021: DEFLUX INJECTABLE GEL
FDA PMA supplement · Normal 180 Day Track · Palette Life Sciences
Key facts
| Original PMA | P000029 |
|---|---|
| Supplement number | S021 |
| Supplement type | Normal 180 Day Track |
| Reason for the supplement | Change Design/Components/Specifications/Material |
| Trade name | DEFLUX INJECTABLE GEL |
| Generic name | AGENT, BULKING, INJECTABLE FOR GASTRO-UROLOGY USE |
| Applicant | Palette Life Sciences |
| Product code | LNM |
| Received date | Mar 5, 2007 |
| Decision date | Jul 21, 2008 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: